ES8701161A1 - Un procedimiento para preparar derivados de piridiloxi - Google Patents

Un procedimiento para preparar derivados de piridiloxi

Info

Publication number
ES8701161A1
ES8701161A1 ES547458A ES547458A ES8701161A1 ES 8701161 A1 ES8701161 A1 ES 8701161A1 ES 547458 A ES547458 A ES 547458A ES 547458 A ES547458 A ES 547458A ES 8701161 A1 ES8701161 A1 ES 8701161A1
Authority
ES
Spain
Prior art keywords
image
derivatives
pyridyloxy
pyridyloxy derivatives
efficacious
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES547458A
Other languages
English (en)
Other versions
ES547458A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ikeda Mohando Co Ltd
Original Assignee
Ikeda Mohando Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP20669084A external-priority patent/JPS6185365A/ja
Priority claimed from JP5020785A external-priority patent/JPS61207375A/ja
Application filed by Ikeda Mohando Co Ltd filed Critical Ikeda Mohando Co Ltd
Publication of ES547458A0 publication Critical patent/ES547458A0/es
Publication of ES8701161A1 publication Critical patent/ES8701161A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE PIRIDILOXI, DE FORMULA (I). CONSISTE EN LA REACCION DE UN COMPUESTO DE FORMULA (II), CON UN COMPUESTO DE FORMULA (III), (IV) O (V), EN UN DISOLVENTE ORGANICO INERTE O EN SU AUSENCIA, A UNA TEMPERATURA DE C20JC O SUPERIOR; SEGUIDA DE LA REACCION DEL PRODUCTO FORMADO CON UNA AMINA DE FORMULA R1NHR2, PARA OBTENER EL COMPUESTO DE FORMULA (I), EN LAS QUE E Y F REPRESENTAN OXIGENO O AZUFRE, HAL ES HALOGENO, R20 Y R30 SON ALQUILO INFERIOR, P VALE 0, 1 O 2 Y X, Z, R1 Y R2 PUEDEN SER VARIOS RADICALES. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE ULCERAS DEL APARATO DIGESTIVO.
ES547458A 1984-10-02 1985-10-01 Un procedimiento para preparar derivados de piridiloxi Expired ES8701161A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP20669084A JPS6185365A (ja) 1984-10-02 1984-10-02 アミノアルキルピリジルオキシ誘導体
JP5020785A JPS61207375A (ja) 1985-03-12 1985-03-12 ピリジルオキシ誘導体

Publications (2)

Publication Number Publication Date
ES547458A0 ES547458A0 (es) 1986-11-16
ES8701161A1 true ES8701161A1 (es) 1986-11-16

Family

ID=26390658

Family Applications (1)

Application Number Title Priority Date Filing Date
ES547458A Expired ES8701161A1 (es) 1984-10-02 1985-10-01 Un procedimiento para preparar derivados de piridiloxi

Country Status (7)

Country Link
US (1) US4710498A (es)
EP (1) EP0177016B1 (es)
AU (1) AU583536B2 (es)
CA (1) CA1275097A (es)
DE (2) DE3587416T2 (es)
DK (1) DK171350B1 (es)
ES (1) ES8701161A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
US4912101A (en) * 1987-03-13 1990-03-27 Fujirebio Kabushiki Kaisha 4-aminomethyl-pyridyl-2-oxy derivatives having anti-ulcer activity
JPH0613486B2 (ja) * 1987-12-07 1994-02-23 株式会社池田模範堂 ピリミドン誘導体及びその医薬的に許容される塩
WO1992013854A1 (fr) * 1991-01-30 1992-08-20 Central Glass Company, Limited Compose de phtalimide et sa production
ATE164574T1 (de) * 1992-08-07 1998-04-15 Fujirebio Kk Verfahren zur herstellung von aminobutene- derivate
US5872139A (en) * 1996-06-17 1999-02-16 American Home Products Corporation Heterocyclymethylamino derivatives of cyclobutene-3,4-diones
US6436972B1 (en) 2000-04-10 2002-08-20 Dalhousie University Pyridones and their use as modulators of serine hydrolase enzymes
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4166857A (en) * 1975-07-03 1979-09-04 Smith Kline & French Laboratories Limited N-Hetero substituted cyclobutenones
US4120968A (en) * 1975-07-31 1978-10-17 Smith Kline & French Laboratories Limited Heterocyclic alkylaminocyclobutenediones
NZ186511A (en) 1977-03-19 1980-11-14 Smith Kline French Lab 3-substituted alkylamino-6-substituted alkyl-1,2,4-triazin-5-ones and pharmaceutical compositions 3-substituted thio-1,2,4-triazin-5-ones
FR2437392A1 (fr) 1978-06-30 1980-04-25 Rhone Poulenc Ind Stabilisation du trichloro-1,1,1 ethane
IL60944A (en) 1979-09-04 1987-11-30 Bristol Myers Co 3,4-disubstituted-1,2,5-thiadiazole-1-oxides and 1,1 dioxides,process for their preparation and pharmaceutical compositions comprising them
CA1155842A (en) * 1980-03-29 1983-10-25 Thomas H. Brown Compounds
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
US4503051A (en) * 1981-05-18 1985-03-05 Bristol-Myers Company Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
US4808589A (en) * 1982-02-20 1989-02-28 Smith Kline & French Laboratories Limited Pyrimidone derivatives
KR840004100A (ko) 1982-03-17 1984-10-06 데비드 마틴 워터스 피리딘 유도체
EP0089765A3 (en) * 1982-03-17 1984-05-23 Smith Kline & French Laboratories Limited Pyridine derivatives
JPS5984867A (ja) * 1982-10-02 1984-05-16 スミス・クライン・アンド・フレンチ・ラボラトリ−ス・リミテツド ジオキソシクロブテン誘導体
US4521625A (en) * 1982-10-02 1985-06-04 Smith Kline & French Laboratories Limited Dioxocyclobutene compounds
ZA839248B (en) * 1982-12-14 1984-10-31 Smith Kline French Lab Pyridine derivatives
EP0112704B1 (en) * 1982-12-23 1987-10-07 Smith Kline & French Laboratories Limited Pyridine derivatives
US4440933A (en) * 1983-03-16 1984-04-03 Bristol-Myers Company Process for preparing 1,2,5-thiadiazoles
DE3513184A1 (de) * 1985-04-12 1986-10-16 Ludwig Heumann & Co GmbH, 8500 Nürnberg 1,3,4-thiadiazolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
DE3587416D1 (de) 1993-07-29
DE3587416T2 (de) 1993-09-30
EP0177016B1 (en) 1993-06-23
DK448885D0 (da) 1985-10-02
EP0177016A3 (en) 1986-12-03
ES547458A0 (es) 1986-11-16
DK171350B1 (da) 1996-09-16
DK448885A (da) 1986-04-03
DE177016T1 (de) 1986-11-06
US4710498A (en) 1987-12-01
AU4813685A (en) 1986-04-10
AU583536B2 (en) 1989-05-04
EP0177016A2 (en) 1986-04-09
CA1275097A (en) 1990-10-09

Similar Documents

Publication Publication Date Title
AU583055B2 (en) Tetralin derivatives, their preparation and their use
AU553338B2 (en) Redox indicators
ZA862289B (en) Application of azolylmethyloxiranes for the treatmazolylmethyloxiranes,their preparation and their uent of viral diseases se as crop protection agents
ES8500242A1 (es) Procedimiento para la preparacion de derivados de imidazol
NZ208831A (en) Imidazolium derivatives and pharmaceutical compositions
ES8305380A1 (es) "procedimiento para la preparacion de derivados de 6-metilprednisolona".
EP0136702A3 (en) Cyclohexenol derivatives, process for their preparation and their use in combating undesirable plant growth
MY102277A (en) Quinoline compounds
AU548396B2 (en) 2-aryl-3,4-diazabicyclo(4.n.0)alk-2-en-5-ones
ES8701161A1 (es) Un procedimiento para preparar derivados de piridiloxi
DE3477488D1 (en) Polymethoxybenzyl piperazine derivatives, processes for their preparation and pharmaceutical compositions containing said derivatives
MY100829A (en) Cyclopentyl ethers and their preparation and pharmaceutical formulation
ES8703456A1 (es) Procedimiento para preparar derivados de nitrofurano
AU578295B2 (en) Phenyl-substituted naphthyridines and their use as anti-ulcer drugs
EP0171147A3 (en) Anti-diabetic compounds
EP0202661A3 (en) Isolation of castanospermine and its use as an antidiabetic agent
ES8600758A1 (es) Procedimiento para preparar derivados de1,3-dioxolanilo
ES2002207A6 (es) Un metodo para producir derivados de glucosilmoranolina
ES8706129A1 (es) Un procedimiento para la preparacion de derivados de imidazol triciclicos
ES8606852A1 (es) Procedimiento de obtencion de fenilbenzoilureas
DE3272640D1 (en) Thiadiazole derivatives, process for their preparation, and their use in combatting unwanted plant growth
ES467886A1 (es) Procedimiento para la preparacion de derivados de acido oleanoico.
ES8605800A1 (es) Procedimiento para la fabricacion de nuevos compuestos cina-moicos
ES8703847A1 (es) Procedimiento para la obtencion de derivados de sulfonilgua-nidinopirimidina
ES479033A1 (es) Un procedimiento para la preparacion de derivados de n-iminometil piperidina.